REQUEST A DEMO
Total
USD $0.00
Search more companies

Novo Nordisk Pharma D.O.O. Beograd (Serbia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Novo Nordisk Pharma D.O.O. Beograd Profile Updated: September 30, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Novo Nordisk Pharma D.O.O. Beograd is an enterprise located in Serbia, with the main office in Belgrade. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was first established on August 29, 2005. It currently has a total number of 63 (2024) employees. In its most recent financial highlights, the company reported a net sales revenue increase of 15.88% in 2024. Its’ total assets recorded a growth of 22.54%.

Headquarters
Milutina Milankovica 9 B
Belgrade; Belgrade;

Contact Details: Purchase the Novo Nordisk Pharma D.O.O. Beograd report to view the information.

Website: http://www.novonordisk.rs

Basic Information
Total Employees:
Purchase the Novo Nordisk Pharma D.O.O. Beograd report to view the information.
Registered Capital:
Purchase the Novo Nordisk Pharma D.O.O. Beograd report to view the information.
Financial Auditors:
Purchase the Novo Nordisk Pharma D.O.O. Beograd report to view the information.
Incorporation Date:
August 29, 2005
Key Executives
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Member of the Supervisory Board
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Novo Nordisk Pharma D.O.O. Beograd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RSD. Absolute financial data is included in the purchased report.
Net sales revenue
15.88%
Total Operating Revenue
15.88%
Operating Profit
11.75%
EBITDA
12.01%
Net Profit/Loss for the Period
16.1%
Total Assets
22.54%
Total Equity
29.14%
Operating Profit Margin
-0.13%
Net Profit Margin
0%
Return on Equity (ROE)
-2.53%
Quick Ratio
0.07%
Cash Ratio
0.1%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?